[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@FrillePelle Avatar @FrillePelle FrillePelle

FrillePelle posts on X about $canta, och, discussions, generated the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks

Social topic influence $canta, och, discussions, generated, breakthrough, news about, $4768t, $4578t, ssc, cart

Top assets mentioned AbbVie Inc (ABBV)

Top Social Posts #

Top posts by engagements in the last XX hours

"Dont think yesterdays news about the withdrawal of the appeal against one of Cantargias patents on IL1RAP lowers the external interest for Cantargia and their antibodies $CANTA 💪🤞🤝"
@FrillePelle Avatar @FrillePelle on X 2024-05-17 14:24:18 UTC XXX followers, 1252 engagements

"Live Update: Cantargia Redeye will have a live update with Cantargia at XXXXX in which we will interview CEO Damian Marron about the deal with Otsuka Pharmaceutical. $CANTA"
@FrillePelle Avatar @FrillePelle on X 2025-07-15 11:31:05 UTC XXX followers, XXX engagements

"The results in 2nd line non-squamous non-small cell lung cancer are very strong $CANTA #CANTARGIA"
@FrillePelle Avatar @FrillePelle on X 2025-07-17 07:21:52 UTC XXX followers, XXX engagements

"Targeting IL-1 controls refractory pityriasis rubra pilaris "With the central role of IL-1 underscoring its potential as a therapeutic target" Would be interesting to see Cantargia's CAN10 in this setting $CANTA IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2024-07-04 07:12:13 UTC XXX followers, XXX engagements

"IL1RAP - A magic bullet candidate for immunotherapy of human malignancies Cantargia lngst fram och med patenten p denna magiska kula $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-02-16 08:45:21 UTC XXX followers, 1054 engagements

"Integrated single-cell and transcriptome sequencing data reveal the value of IL1RAP in gastric cancer microenvironment and prognosis Conclusion: IL1RAP plays a critical role in the tumor microenvironment of gastric cancer $CANTA #CANTARGIA #IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2025-06-30 07:53:45 UTC XXX followers, XXX engagements

""our results show that both tumor- and the TME-derived IL-1 contribute to the progression of TNBC in mice" $CANTA #IL1RAP #CANTARGIA #TRIFOUR"
@FrillePelle Avatar @FrillePelle on X 2024-04-08 14:21:20 UTC XXX followers, XXX engagements

"However it's the IL1RAP protein that offers a glimmer of hope These findings underscore the potential of IL1RAP as a promising target for the development of novel therapeutic strategies in CML treatment. CANTARGIA $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-02-19 07:35:04 UTC XXX followers, 1510 engagements

"We have noticed a strong increase in international interest in our antibody CAN10 in recent months and we are well positioned with a unique product. I hope we can build on that international interest and deliver on it. Cantargia $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-03-28 10:00:24 UTC XXX followers, 1798 engagements

"Next week its time for AACR 2024 looking forward to see what more data Cantargia will present and include in their poster think we might get an update clinical progress. $CANTA #AACR2024 #IL1RAP #PDAC"
@FrillePelle Avatar @FrillePelle on X 2024-03-25 12:24:32 UTC XXX followers, 2949 engagements

"This study identifies a role for IL-1RAP in the generation of eosinophilia independent of neutrophil influx and highlights its potential as a novel immunotherapeutic target for the treatment $CANTA #CANTARGIA #IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2025-06-30 08:41:00 UTC XXX followers, 1675 engagements

"Cantargias antibody CAN10 huge potential in autoimmune and inflammatory diseases. $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-04-15 06:51:28 UTC XXX followers, 1775 engagements

"CANTARGIA Conclusions: Data from PDAC patients receiving nadunolimab + GN and experiments in preclinical models suggest that targeting IL1RAP by nadunolimab may combine antitumor activity with potent reduction of CIPN $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-06-24 09:41:31 UTC XXX followers, XXX engagements

"Cantargia will present its promising candidate CAN10 at ABG Sundal Collier next Thursday 11th of June CAN10 is currently in clinical development for autoimmune/inflammatory diseases. $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-06-07 08:16:58 UTC XXX followers, 2193 engagements

"ILRAP blockade mediates anti-fibrotic effects in pancreatic cancer-associated fibroblasts Cantargia's poster will be presented April X 2024 1:30 PM Eastern Time #AACR2024 #PDAC #IL1RAP $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-04-03 08:14:57 UTC XXX followers, 1590 engagements

"Analysts are unanimous on Cantargia they all rate the company with BUY and the target price is well above the current price and ranges from XXX% to XXX% Analysts following Cantargia is Carnegie NORDEA REDEYE Kempen Oppenheimer EF Hutton and Aktiespararna. $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-03-25 10:16:54 UTC XXX followers, 1273 engagements

"we demonstrated that the IL-1RAP CAR-T cells generated in a GMP-like environment could eliminate tumor cells and increase overall survival Nice to see more activity in the IL1RAP field especially when Cantargia is holding the patents #IL1RAP $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-03-07 10:55:23 UTC XXX followers, 1171 engagements

"IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia We show that IL1RAP protein represents an interesting target for ADC development $CANTA #CANTARGIA #IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2025-04-15 10:54:50 UTC XXX followers, 1532 engagements

"Last piece of the puzzle in a partnering deal for Cantargias CAN04 project Must be looking a lot more interesting with fast track and a potential accelerated approval I believe ongoing discussions just got a bit more real. $CANTA 💪🤞"
@FrillePelle Avatar @FrillePelle on X 2025-06-11 07:25:09 UTC XXX followers, 2230 engagements

"The XX of September Cantargias posters at ESMO will be presented it will include updated data and hopefully some more details this is groundbreaking potential with responses and overall survival never seen before in 2nd line after Keytruda treatment $CANTA #IL1RAP #ESMO2024"
@FrillePelle Avatar @FrillePelle on X 2024-09-09 13:12:00 UTC XXX followers, XXX engagements

"Soon time for #AACR2024 this year its a few more contributions to the IL1RAP field then Cantargias The increasing activity around IL1RAP is good news when you are years ahead of everyone else like Cantargia especially when Cantargia has patents on IL1RAP as a target $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-04-04 06:52:20 UTC XXX followers, 2485 engagements

"New data from two clinical trials in XX patients strongly support Nadunolimab efficacy and highlight a unique opportunity using Cantargias antibody nadunolimab in patients after they have progressed on pembrolizumab treatment $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-09-09 05:47:21 UTC XXX followers, XXX engagements

"But good for Cantargia that another company clinically validates their findings in an randomised setting I think $CANTA will get their next step in PDAC up and running soon. With early data next year setting up an accelerated approval it will be a breakthrough in PDAC"
@FrillePelle Avatar @FrillePelle on X 2024-06-19 06:41:49 UTC XXX followers, 1175 engagements

"The differential expression of the IL-1 family and related genes affects the microenvironment changes and survival prognosis of HNSCC patients. Among them IL-1 IL1RAP. $CANTA #IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2024-09-16 08:22:23 UTC XXX followers, XXX engagements

"Later today Cantargia will present more about their second project CAN10 $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-06-11 07:17:42 UTC XXX followers, 1168 engagements

"Cantargia today reported on the progress in the upcoming phase Ib/IIa clinical trial investigating nadunolimab in up to XX patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) this trial is financed through a grant. $CANTA #IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2024-03-27 06:39:30 UTC XXX followers, XXX engagements

"Immunotherapeutic targeting of surfaceome heterogeneity in AML Interestingly four of these genes encode proteins that were identified as pan-AML antigens (IL1RAP) and that are targeted by therapeutic antibodies Cantargia soon in a clinical trial $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-06-05 11:11:10 UTC XXX followers, XXX engagements

"CAN10 with its broader mechanism of action is clearly creating interest in the hot area of immunological and inflammatory disease segment. Cantargia $CANTA IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2024-03-19 07:39:51 UTC XXX followers, 1667 engagements

"Cantargia publishes preclinical data on the potential of CAN10 in systemic sclerosis in a leading scientific journal We are really pleased that the important results supporting CAN10 development in systemic sclerosis is recognized in a leading scientific journal" $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-04-10 06:51:54 UTC XXX followers, 1708 engagements

"Decoding immune-related gene-signatures in colorectal neoplasia The overexpression of IL1RAP which encodes a part of the IL1 receptor heterodimer underscores the activation of the IL1 signaling pathway within tumor environments CANTARGIA $CANTA #IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2024-06-25 11:43:35 UTC XXX followers, XXX engagements

"IL-1RAP: novel target for chemotherapy-induced neuropathy Exciting to see what more to come at ASCO an abstract on the subject was presented with Cantargia's antibody Nadunolimab $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-08-23 09:15:03 UTC XXX followers, XXX engagements

"Cantargia's antibody CAN10 is generating alot of international interest hopefully $CANTA can make the most of it very soon"
@FrillePelle Avatar @FrillePelle on X 2024-04-10 07:12:40 UTC XXX followers, XXX engagements

"IL1RAP blockade mediates anti-fibrotic effects in pancreatic cancer-associated fibroblasts Cantargias poster presented yesterday at #AACR2024 Nadunolimab has the potential to counteract the fibrotic progression in #PancreaticCancer $CANTA #IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2024-04-09 04:55:39 UTC XXX followers, XXX engagements

"Avalo expects net upfront proceeds to be approximately $XXX million Svenska Cantargia bedriver just nu en fas I-studie med bolagets lkemedelskandidat CAN10 som ocks r en antikropp fr behandling av autoimmuna och inflammatoriska sjukdomar. $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-03-28 07:40:42 UTC XXX followers, 1455 engagements

"CANTARGIA One of the reasons that Im here as the CEO is to make sure that we can execute on a value creation transaction for the company that will allow us to take those next steps $CANTA #IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2025-03-27 13:18:07 UTC XXX followers, 2517 engagements

"Great news from CANTARGIA Unique properties that makes CAN10 a potent blocker of the disease-promoting inflammatory cytokines IL-1 IL-33 and IL-36. This mechanism could be of high value in the treatment of a large number of diseases. $CANTA #IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2024-04-17 19:08:54 UTC XXX followers, XXX engagements

"The importance of inflammation in the occurrence and development of tumors has been fully confirmed. IL-1 is an attractive target The target IL1RAP may become a breakthrough in improving tumor treatment efficacy. CANTARGIA $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-09-13 06:31:43 UTC XXX followers, XXX engagements

"IL-1RAP the word is out there Cantargias research and strategy has been validated from others before but Pfizer is a big deal especially when Cantargia are the ones with patents on Il-1RAP as a target $CANTA"
@FrillePelle Avatar @FrillePelle on X 2025-04-10 07:00:49 UTC XXX followers, XXX engagements

"The dense fibrotic tissue and tumour micro environment in PDAC tumours as well as KRAS mutations has been discussed as keys to get efficacy in treating PDAC clinical and preclinical data suggests Cantargias antibody Nadunolimab has an effect on all of the above $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-03-06 08:08:42 UTC XXX followers, XXX engagements

"Targeting the CiMs/IL36G signaling axis may be a useful therapeutic option for patients with cancer cachexia CANTARGIA $CANTA Targeting #IL1RAP inhibitit signaling of IL-1 IL-33 and IL-36"
@FrillePelle Avatar @FrillePelle on X 2024-09-13 06:42:00 UTC XXX followers, XXX engagements

"So many results articles and data all of them points in the same direction Cantargia's development and approach to block IL-1 with antibodies directed att IL1RAP has great potential and this is not only supported by their own studies. $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-05-30 12:39:06 UTC XXX followers, 1529 engagements

"This phase Ib/IIa trial with XX patients in myeloid leukemia and myelodysplastic syndrome is sponsored by the US DOD so the costs for Cantargia will be limited. The trial is a valuable addition to the pipeline as it will be the first clinical trial in hematologic cancers $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-03-27 08:13:36 UTC XXX followers, XXX engagements

"OPPENHEIMER - CANTARGIA Its Time To Start Following CAN10 "but we also believe (from recent discussions with management) that a more concerted messaging on CAN10s development is in the worksso stay tuned" Stock Rating: OUTPERFORM 12-18 mo. Price Target XX SEK $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-03-25 07:54:46 UTC XXX followers, 2109 engagements

"I believe most is in place to start the trial more news around Cantargia's new DoD trial soon to come. $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-08-21 06:59:09 UTC XXX followers, XXX engagements

"highlight the potential of nadunolimab as a cancer therapy which may provide antitumor effects together with a protective effect when combined with chemotherapy. These results clearly warrant further development CANTARGIA $CANTA #IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2024-10-10 05:42:39 UTC XXX followers, XXX engagements

"Cancer researchers are always looking for new ways to target cancer cells without harming healthy cells. One area researchers are exploring is a protein called IL1RAP which is found in higher amounts on the surface of cancer cells $CANTA #CANTARGIA"
@FrillePelle Avatar @FrillePelle on X 2024-08-26 07:00:24 UTC XXX followers, XXX engagements

"The fact that Cantargias ADC studies were performed with ImmunoGen (now part of AbbVie) suggests some level of interest from big pharma. $CANTA"
@FrillePelle Avatar @FrillePelle on X 2025-03-26 12:49:49 UTC XXX followers, XXX engagements

"NALIRIFOX approved with an improved OS of XXX months Cantargia's data on all PDAC patients in CANFOUR study receiving Nadunolimab in combination with Gem/Nab chemotherapy was XXXX months in the IL1RAP High Group the OS was XXXX months $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-02-14 07:15:28 UTC XXX followers, 1187 engagements

"We should probably get new regarding Cantargia's DoD sponsored trial in Leukemia very soon it is guided to be started mid 2024. Will be interesting to see Nadunolimab in hematologic cancers $CANTA"
@FrillePelle Avatar @FrillePelle on X 2024-06-05 07:13:32 UTC XXX followers, 1673 engagements

"Cantargia reports start of multiple dosing part in CAN10 phase X clinical trial As this part of the phase X trial evaluates participants with psoriasis significant data will be generated which will be useful to investigate the CAN10 mechanism of action $CANTA #IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2024-09-30 12:02:52 UTC XXX followers, XXX engagements

"New presentation on Cantargia's webpage Extensive newsflow during 2025 CAN10 next steps positive FDA feedback on phase X trial with strong endorsement from KOLs on lead indication PDAC next steps Interim analysis opens for early MAA $CANTA #IL1RAP"
@FrillePelle Avatar @FrillePelle on X 2025-03-28 07:50:14 UTC XXX followers, 1374 engagements

"CANTARGIA New Nadunolimab data will be presented at ESMO Congress. The results clearly highlight potential activity in patients no longer responding to PD1-s Watch out the full datasets will be disclosed Sep XX $CANTA #IL1RAP #ESMO2024"
@FrillePelle Avatar @FrillePelle on X 2024-09-09 17:00:36 UTC XXX followers, XXX engagements